E-Scape Bio
Welcome to e-Scape Bio !
South San Francisco, United States · Founded 2015 · $136.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2015
- Business Model
- B2B
- Website
- e-scapebio.com
- Total Funding
- $136.0M
- Last Round
- $73.0M Series BSep 2020
- Rounds
- 2
About
E-Scape Bio is a clinical-stage biopharma developing precision small-molecule therapies for genetically defined neurodegenerative diseases (Alzheimer's, Parkinson's). Targets apoE4 and similar genetic pathways.
Summary
E-Scape Bio is a Biotech company based in South San Francisco, United States, founded in 2015. It has raised $136.0M in total across 2 rounds, most recently a $73.0M Series B round in Sep 2020. Investors include Wellington Management, Sutter Hill and Avidity Partners.
Tech & App Stack
1 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Sep 2020
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Wellington Management
1 round
Sutter Hill
1 round
Avidity Partners
1 round
CAM Capital
1 round
New Leaf Ventures
1 round
Rock Springs Capital
1 round
Surveyor Capital
1 round
Lilly Asia Ventures
1 round
Osage University Partners
1 round
OrbiMed
1 round
Johnson & Johnson Innovation
1 round
Novo Seeds
1 round
Novartis Venture Fund
1 round
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...